TMEM100 is identified as one of the most sensitive BMP9-responsive genes in ECs (Somekawa et al., 2012) and it has been found that the decreased TMEM100 expression is linked to the development of the vascular pathology of HHT (Moon et al., 2015). The gene discussed is TMEM100; the disease is hereditary hemorrhagic telangiectasia.